ipilimumab

ipilimumab is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or .

Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:

-- The first section of this topic is shown below --

General

Genetic Implications: Genetic Implications

Pronunciation:
i-pil-li-moo-mab

To hear audio pronunciation of this topic, purchase a subscription or log in.

Trade Name(s)

  • Yervoy

Ther. Class.

antineoplastics

Pharm. Class.

monoclonal antibodies

temporary class

cytotoxic T-lymphocyte antigen 4 inhibitors

-- To view the remaining sections of this topic, please or --

General

Genetic Implications: Genetic Implications

Pronunciation:
i-pil-li-moo-mab

To hear audio pronunciation of this topic, purchase a subscription or log in.

Trade Name(s)

  • Yervoy

Ther. Class.

antineoplastics

Pharm. Class.

monoclonal antibodies

temporary class

cytotoxic T-lymphocyte antigen 4 inhibitors

There's more to see -- the rest of this topic is available only to subscribers.